Filing Flows › Sotera Health (SHC) › Q2 2026 › vs Q1 2026
Sotera Health (SHC) Q2 2026 vs Q1 2026 (quarter over quarter)
Sotera Health's revenue rose $41.3M (+15%) from $280M in Q1 2026 to $321M in Q2 2026. The biggest changes: Sterigenics +$25.4M (+14%); Nelson Labs +$8.8M (+17%); Nordion +$7.1M (+17%). Gross margin 55.4% against 52.5% (+2.9 pts).
Sotera Health, Q2 2026: revenue $321M (+9% year over year), operating margin 24.3%, net earnings $53.6M, operating cash flow $88.5M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 55.4% | 52.5% | +2.9 pts |
| Operating margin | 24.3% | 15.2% | +9.1 pts |
| Net margin | 16.7% | 9.5% | +7.2 pts |
| Free cash flow margin | 13.1% | -6.0% | +19.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Sterigenics | $212M | $186M | $25.4M | +14% |
| Nelson Labs | $60.7M | $51.9M | $8.8M | +17% |
| Nordion | $49.1M | $42.0M | $7.1M | +17% |
| Revenue | $321M | $280M | $41.3M | +15% |
| Gross profit | $178M | $147M | $30.9M | +21% |
| Cost of revenue | $143M | $133M | $10.4M | +8% |
| Operating profit | $78.1M | $42.6M | $35.4M | +83% |
| Operating expenses | $99.9M | $104M | −$4.5M | -4% |
| Pre-tax earnings | $78.1M | $42.6M | $35.4M | +83% |
| SG&A | $68.2M | $68.2M | −$55K | -0.1% |
| Other operating costs | $31.8M | $36.2M | −$4.5M | -12% |
| Net earnings | $53.6M | $26.6M | $27.1M | +102% |
| Income tax | $24.4M | $16.0M | $8.4M | +52% |
| Depreciation & amortization | $33.4M | $30.8M | $2.6M | +8% |
| Share-based compensation | $7.2M | $14.4M | −$7.2M | -50% |
| Working capital & other | $5.8M | $42.4M | −$36.6M | -86% |
| Operating cash flow | $88.5M | $29.4M | $59.1M | +201% |
| Free cash flow (OCF − capex) | $42.0M | −$16.7M | $58.8M | — |
| Capital expenditures | $46.4M | $46.2M | $283K | +0.6% |
Questions
How much did Sotera Health's revenue grow quarter over quarter in Q2 2026?
Sotera Health's revenue rose $41.3M (+15%) from $280M in Q1 2026 to $321M in Q2 2026.
What drove Sotera Health's revenue change in Q2 2026?
Sterigenics +$25.4M (+14%); Nelson Labs +$8.8M (+17%); Nordion +$7.1M (+17%).